CAV2 Regulates Mir-4723/Wnt7A Signalling Axis through Endocytosis and Epithelial-Mesenchymal Transition to Promote Proliferation, Invasion, and Metastasis of Pancreatic Cancer Cells

Abstract

Background: Pancreatic cancer is one of the most aggressive malignancies globally, with no improvement in the cure rates yet.Caveolin-2 (CAV2) has been repeatedly reported to play an important role in cellular transport and signalling and in exhibiting a pro-oncogenic response in a variety of tumours, although its specific action mechanisms in pancreatic cancer are not well documented. MiRNA is recognized as a therapeutic target for a variety of tumours, making it an important regulator of the Wnt/β-catenin signalling pathway. MiR-4723/Wnt7A constitutes an oncogenic signalling axis in pancreatic cancer by targeting and inhibiting Wnt7A through the activation of MiR4723, but its molecular action mechanism remains unexplored. Therefore, in the present study, we investigated the effect of CAV2 on the MiR-4723/Wnt7A pathway and its action mechanism. Methods: We employed TCGA, the GEO database for bioinformatics analysis, cell proliferation assay, wound healing assay, Transwell assay, colony-forming assay, qRT-PCR, and Western blotting to validate the cancer-promoting role of CAV2 in pancreatic cancer and to determine its potential target WNT7A. We then explored CAV2 as a positive regulator of the Wnt7A/β-catenin pathway through immunofluorescence assay, qRT-PCR, and Western blotting. Database analyses, CCK-8 and qRT-PCR revealed that MiR-4723 is an oncogene in pancreatic cancer. Luciferase assay and qRT-PCR revealed that MiR-4723 is a negative regulator of the Wnt7A/β-catenin pathway. To investigate the mechanism of CAV2 action on MiR-4723/Wnt7A, we detected the gene expression of CAV2 through qRT-PCR after MiR-4723 overexpression. Several genes related to endocytosis and epithelial-mesenchymal transition (EMT) were subsequently analysed through immunofluorescence, Western blotting, and qRT-PCR. Results: Overexpression of CAV2 promotes invasion, migration, cloning and metastasis of pancreatic cancer cells. Overexpression of MiR-4723 inhibits CAV2 expression. Here, we are the first to demonstrate that CAV2 exerts a pro-carcinogenic effect on pancreatic cancer through the activation of the Wnt7A/β-catenin signalling pathway. Conclusion: CAV2 can regulate the MiR-4723/Wnt7A signalling axis in pancreatic cancer cell lines by inhibiting endocytosis and promoting EMT, thereby fulfilling the mechanism pro-carcinogenic effects.

Anatomical landscape of oral squamous cell carcinoma: A single cancer center study in UAE

“…Additionally, our analysis revealed that polymorphism of IGF2BP2 gene that is differentially expressed in carcinoma of FOM [ 35 ] was found to be associated with less favorable oral cancer clinical characteristics [ 36 ]. DLGAP4 and COL4A6 that were found to be differentially expressed in carcinoma of anterior 2/3 of the tongue were found to be associated with poor overall survival in cancer, and the COL4A family was discovered to be a major component of the basement membrane (BM) that has recently been found to be involved in tumor angiogenesis and progression [ 37 ].…”

Downregulation of praja2 restrains endocytosis and boosts tyrosine kinase receptors in kidney cancer

“…When expressed in cells, miR-155 inhibits endogenous praja2 accumulation and prevents ligand-induced endocytosis of EGFR. The role of other miRNAs in the endocytic trafficking and RTK turnover as well as their impact on cancer cell growth and metastasis have been previously reported 67 – 69 . However, to our knowledge, our work provides the first demonstration of the existence of a signaling circuitry that mechanistically links oncogenic miRNAs to the ubiquitin pathway and RTK turnover.…”